BLRX
Price
$3.65
Change
-$0.24 (-6.17%)
Updated
Aug 7 closing price
Capitalization
14.2M
KURA
Price
$5.96
Change
-$0.07 (-1.16%)
Updated
Aug 7 closing price
Capitalization
515.99M
83 days until earnings call
Interact to see
Advertisement

BLRX vs KURA

Header iconBLRX vs KURA Comparison
Open Charts BLRX vs KURABanner chart's image
BioLineRx
Price$3.65
Change-$0.24 (-6.17%)
Volume$36.16K
Capitalization14.2M
Kura Oncology
Price$5.96
Change-$0.07 (-1.16%)
Volume$990.13K
Capitalization515.99M
BLRX vs KURA Comparison Chart in %
Loading...
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLRX vs. KURA commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLRX is a StrongBuy and KURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (BLRX: $3.65 vs. KURA: $5.96)
Brand notoriety: BLRX and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLRX: 31% vs. KURA: 80%
Market capitalization -- BLRX: $14.2M vs. KURA: $515.99M
BLRX [@Biotechnology] is valued at $14.2M. KURA’s [@Biotechnology] market capitalization is $515.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLRX’s FA Score shows that 1 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • BLRX’s FA Score: 1 green, 4 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, both BLRX and KURA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLRX’s TA Score shows that 4 TA indicator(s) are bullish while KURA’s TA Score has 2 bullish TA indicator(s).

  • BLRX’s TA Score: 4 bullish, 5 bearish.
  • KURA’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BLRX is a better buy in the short-term than KURA.

Price Growth

BLRX (@Biotechnology) experienced а -8.29% price change this week, while KURA (@Biotechnology) price change was -1.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

KURA is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KURA($516M) has a higher market cap than BLRX($14.2M). KURA YTD gains are higher at: -31.573 vs. BLRX (-57.360). BLRX has higher annual earnings (EBITDA): 8.5M vs. KURA (-177.18M). KURA has more cash in the bank: 658M vs. BLRX (26.4M). BLRX has less debt than KURA: BLRX (13.7M) vs KURA (19.4M). KURA has higher revenues than BLRX: KURA (68M) vs BLRX (22.3M).
BLRXKURABLRX / KURA
Capitalization14.2M516M3%
EBITDA8.5M-177.18M-5%
Gain YTD-57.360-31.573182%
P/E RatioN/AN/A-
Revenue22.3M68M33%
Total Cash26.4M658M4%
Total Debt13.7M19.4M71%
FUNDAMENTALS RATINGS
BLRX vs KURA: Fundamental Ratings
BLRX
KURA
OUTLOOK RATING
1..100
6977
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
23
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9697
PRICE GROWTH RATING
1..100
6264
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BLRX's Valuation (13) in the Pharmaceuticals Other industry is in the same range as KURA (23) in the Biotechnology industry. This means that BLRX’s stock grew similarly to KURA’s over the last 12 months.

BLRX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as KURA (100) in the Biotechnology industry. This means that BLRX’s stock grew similarly to KURA’s over the last 12 months.

BLRX's SMR Rating (96) in the Pharmaceuticals Other industry is in the same range as KURA (97) in the Biotechnology industry. This means that BLRX’s stock grew similarly to KURA’s over the last 12 months.

BLRX's Price Growth Rating (62) in the Pharmaceuticals Other industry is in the same range as KURA (64) in the Biotechnology industry. This means that BLRX’s stock grew similarly to KURA’s over the last 12 months.

BLRX's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as KURA (100) in the Biotechnology industry. This means that BLRX’s stock grew similarly to KURA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLRXKURA
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 17 days ago
81%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EVSYX26.41N/A
N/A
Allspring Disciplined US Core Admin
HQIAX21.02N/A
N/A
Hartford Equity Income A
DNLYX60.87N/A
N/A
BNY Mellon Active MidCap Y
GIDUX7.95N/A
N/A
Goldman Sachs Intl Eq Div & Prem R6
LCAGX15.81N/A
N/A
Lord Abbett International Growth C

BLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLRX has been loosely correlated with PYXS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BLRX jumps, then PYXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLRX
1D Price
Change %
BLRX100%
-6.17%
PYXS - BLRX
41%
Loosely correlated
+1.90%
KURA - BLRX
37%
Loosely correlated
-1.16%
DWTX - BLRX
33%
Loosely correlated
+0.55%
TAOX - BLRX
30%
Poorly correlated
-4.34%
AEON - BLRX
28%
Poorly correlated
+0.32%
More